|
|
|
Volumn 14, Issue 5, 2007, Pages 3692-3696
|
|
The importance of the dose of etoposide in the initial treatment of metastatic germ cell tumors and advances in management of patients that relapse.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
BLEOMYCIN;
CISPLATIN;
ETOPOSIDE;
PACLITAXEL;
ARTICLE;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
DRUG COMBINATION;
HUMAN;
MALE;
NEOPLASM;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SALVAGE THERAPY;
TESTIS TUMOR;
TREATMENT OUTCOME;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
BLEOMYCIN;
CISPLATIN;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
ETOPOSIDE;
HUMANS;
MALE;
NEOPLASMS, GERM CELL AND EMBRYONAL;
PACLITAXEL;
RECURRENCE;
RETROSPECTIVE STUDIES;
SALVAGE THERAPY;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 38449090839
PISSN: 11959479
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
